Skip to main content
Adriano Piris, MD, Pathology, Boston, MA, Brigham and Women's Hospital

AdrianoPirisMD

Pathology Boston, MA

Dermatopathology, Anatomic Pathology, Clinical Pathology

Instructor in Pathology, Massachusetts General Hospital

Dr. Piris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Piris' full profile

Already have an account?

Education & Training

  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Dermatopathology, 2006 - 2007
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1998 - 2000
  • Universidad Nacional de Asuncion Faculty of Medicine
    Universidad Nacional de Asuncion Faculty of MedicineClass of 1993

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2006 - 2025
  • RI State Medical License
    RI State Medical License 2020 - 2024
  • OH State Medical License
    OH State Medical License 2017 - 2022
  • FL State Medical License
    FL State Medical License 2017 - 2022
  • VA State Medical License
    VA State Medical License 2018 - 2020
  • NH State Medical License
    NH State Medical License 2017 - 2019
  • NY State Medical License
    NY State Medical License 2017 - 2019
  • American Board of Pathology Pathology - Anatomic
  • American Board of Pathology Dermatopathology
  • Join now to see all

Publications & Presentations

PubMed

Lectures

  • Melanoma and Mimics: New Diagnostic and Treatment Modalities 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/3/2019

Press Mentions

  • Large-Scale Screen of Drug Combinations Identifies Potential Treatment for Resistant, BRAF-Mutant Melanoma
    Large-Scale Screen of Drug Combinations Identifies Potential Treatment for Resistant, BRAF-Mutant MelanomaOctober 26th, 2015

Hospital Affiliations